Overview
Shino Shimada practices in Tokyo, Japan. Shimada is rated as an Experienced expert by MediFind in the treatment of Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE). Their top areas of expertise are 1p36 Deletion Syndrome, Megalencephalic Leukoencephalopathy with Subcortical Cysts, CACH Syndrome, and Vici Syndrome.
Their clinical research consists of co-authoring 42 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- 1p36 Deletion SyndromeShimada isDistinguished. Learn about 1p36 Deletion Syndrome.
- Advanced
- CACH SyndromeShimada isAdvanced. Learn about CACH Syndrome.
- Megalencephalic Leukoencephalopathy with Subcortical Cysts
- Experienced
- Achalasia Microcephaly SyndromeShimada isExperienced. Learn about Achalasia Microcephaly Syndrome.
- Alternating Hemiplegia of Childhood
- Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)
- Benign Familial Neonatal SeizuresShimada isExperienced. Learn about Benign Familial Neonatal Seizures.
- CDKL5 Deficiency DisorderShimada isExperienced. Learn about CDKL5 Deficiency Disorder.
- Corpus Callosum AgenesisShimada isExperienced. Learn about Corpus Callosum Agenesis.